Related Experiment Video
Updated: Jun 6, 2026
A Sensitive Method to Quantify Senescent Cancer Cells
Published on: August 2, 2013
Senescence in tumours: evidence from mice and humans
Manuel Collado1, Manuel Serrano
1Spanish National Cancer Research Centre, Madrid, Spain. mcollado@cnio.es
Abstract:
The importance of cellular senescence, which is a stress response that stably blocks proliferation, is increasingly being recognized. Senescence is prevalent in pre-malignant tumours, and progression to malignancy requires evading senescence. Malignant tumours, however, may still undergo senescence owing to interventions that restore tumour suppressor function or inactivate oncogenes. Senescent tumour cells can be cleared by immune cells, which may result in efficient tumour regression. Standard chemotherapy also has the potential to induce senescence, which may partly underlie its therapeutic activity. Although these concepts are well supported in mouse models, translating them to clinical oncology remains a challenge.
Insights
Cellular senescence, a process blocking cell growth, is crucial in cancer. While tumors can evade senescence, interventions and chemotherapy can induce it, potentially aiding cancer regression, though clinical translation is challenging.
Area of Science:
- Oncology
- Cell Biology
- Immunology
Background:
- Cellular senescence is a stress response that halts cell proliferation.
- Senescence is a critical barrier to tumor development, and cancer progression involves evading this process.
- Malignant tumors can be induced to undergo senescence through therapeutic interventions.
Purpose of the Study:
- To explore the role of cellular senescence in cancer development and regression.
- To discuss the potential of inducing senescence as a cancer therapy.
- To highlight the challenges in translating senescence-based cancer research from mouse models to clinical oncology.
Main Methods:
- Review of existing literature on cellular senescence in cancer.
- Analysis of mechanisms by which senescence is induced or evaded in tumors.
- Examination of the role of the immune system and chemotherapy in senescence-mediated tumor regression.
Main Results:
- Senescence is prevalent in pre-malignant lesions and its evasion is necessary for malignancy.
- Therapeutic strategies can restore tumor suppressor function or inactivate oncogenes to induce senescence in malignant tumors.
- Senescent tumor cells can be eliminated by immune cells, leading to tumor regression.
- Chemotherapy can induce senescence, contributing to its therapeutic efficacy.
Conclusions:
- Cellular senescence plays a complex role in cancer, acting as both a barrier and a potential therapeutic target.
- Inducing senescence in cancer cells, potentially via immune clearance or chemotherapy, offers a promising avenue for cancer treatment.
- Further research is needed to overcome the challenges in translating these findings into effective clinical applications for cancer therapy.
Related Concept Videos
02:15Replicative Cell Senescence
01:12Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
01:20The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
02:43Mouse Models of Cancer Study
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...